101 related articles for article (PubMed ID: 35525372)
1. Germline and somatic genetic variability of oxysterol-related genes in breast cancer patients with early disease of the luminal subtype.
Holý P; Hlaváč V; Ostašov P; Brynychová V; Koževnikovová R; Trnková M; Kopečková K; Měšťáková S; Mrhalová M; Souček P
Biochimie; 2022 Aug; 199():158-169. PubMed ID: 35525372
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer.
Holý P; Brynychová V; Šeborová K; Haničinec V; Koževnikovová R; Trnková M; Vrána D; Gatěk J; Kopečková K; Mrhalová M; Souček P
Mol Oncol; 2023 Oct; 17(10):2074-2089. PubMed ID: 37491786
[TBL] [Abstract][Full Text] [Related]
3. Expression of oxysterol pathway genes in oestrogen-positive breast carcinomas.
Kloudova A; Brynychova V; Vaclavikova R; Vrana D; Gatek J; Mrhalova M; Kodet R; Soucek P
Clin Endocrinol (Oxf); 2017 Jun; 86(6):852-861. PubMed ID: 28342201
[TBL] [Abstract][Full Text] [Related]
4. Plasma oxysterol levels in luminal subtype breast cancer patients are associated with clinical data.
Kloudova-Spalenkova A; Ueng YF; Wei S; Kopeckova K; Peter Guengerich F; Soucek P
J Steroid Biochem Mol Biol; 2020 Mar; 197():105566. PubMed ID: 31874216
[TBL] [Abstract][Full Text] [Related]
5. The expression, immune infiltration, prognosis, and experimental validation of OSBPL family genes in liver cancer.
Tian K; Ying Y; Huang J; Wu H; Wei C; Li L; Chen L; Wu L
BMC Cancer; 2023 Mar; 23(1):244. PubMed ID: 36918840
[TBL] [Abstract][Full Text] [Related]
6. [Application of next-generation sequencing in detection of BRCA1/2 and homologous recombination repair pathway multi-genes germline mutation and correlation analysis].
Chen YL; Zhuo ZL; Liu C; Xie F; Yang ZY; Liu PF; Wang S; Zhao XT
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Mar; 56(3):302-311. PubMed ID: 35381651
[No Abstract] [Full Text] [Related]
7. Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer.
Swan R; Alnabulsi A; Cash B; Alnabulsi A; Murray GI
Oncotarget; 2016 Jul; 7(29):46509-46527. PubMed ID: 27341022
[TBL] [Abstract][Full Text] [Related]
8. FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment.
Wilkins A; Chauhan R; Rust A; Pearson A; Daley F; Manodoro F; Fenwick K; Bliss J; Yarnold J; Somaiah N
Breast Cancer Res Treat; 2018 Aug; 170(3):573-581. PubMed ID: 29700676
[TBL] [Abstract][Full Text] [Related]
9. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
10. Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy.
Ellingson MS; Hart SN; Kalari KR; Suman V; Schahl KA; Dockter TJ; Felten SJ; Sinnwell JP; Thompson KJ; Tang X; Vedell PT; Barman P; Sicotte H; Eckel-Passow JE; Northfelt DW; Gray RJ; McLaughlin SA; Moreno-Aspitia A; Ingle JN; Moyer AM; Visscher DW; Jones K; Conners A; McDonough M; Wieben ED; Wang L; Weinshilboum R; Boughey JC; Goetz MP
Breast Cancer Res Treat; 2015 Sep; 153(2):435-43. PubMed ID: 26296701
[TBL] [Abstract][Full Text] [Related]
11. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
[TBL] [Abstract][Full Text] [Related]
12. Importance of genetic background of oxysterol signaling in cancer.
Holy P; Kloudova A; Soucek P
Biochimie; 2018 Oct; 153():109-138. PubMed ID: 29746893
[TBL] [Abstract][Full Text] [Related]
13. [Germline and Somatic Mutations in Archived Breast Cancer Specimens of Different Subtypes].
Abramov IS; Korneva YS; Shisterova OA; Ikonnikova AY; Emelyanova MA; Lisitsa TS; Krasnov GS; Nasedkina TV
Mol Biol (Mosk); 2021; 55(3):412-421. PubMed ID: 34097676
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol derivatives and breast cancer: oxysterols driving tumor growth and metastasis.
Sawada MI; S Ferreira GD; Passarelli M
Biomark Med; 2020 Oct; 14(14):1299-1302. PubMed ID: 32969241
[No Abstract] [Full Text] [Related]
15. Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling.
Cornen S; Guille A; Adélaïde J; Addou-Klouche L; Finetti P; Saade MR; Manai M; Carbuccia N; Bekhouche I; Letessier A; Raynaud S; Charafe-Jauffret E; Jacquemier J; Spicuglia S; de The H; Viens P; Bertucci F; Birnbaum D; Chaffanet M
PLoS One; 2014; 9(1):e81843. PubMed ID: 24416132
[TBL] [Abstract][Full Text] [Related]
16. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.
Van Asten K; Slembrouck L; Olbrecht S; Jongen L; Brouckaert O; Wildiers H; Floris G; Van Limbergen E; Weltens C; Smeets A; Paridaens R; Giobbie-Hurder A; Regan MM; Viale G; Thürlimann B; Vergote I; Christodoulou E; Van Calster B; Neven P
Oncologist; 2019 Feb; 24(2):165-171. PubMed ID: 30171067
[TBL] [Abstract][Full Text] [Related]
18. Phytosterols Inhibit Side-Chain Oxysterol Mediated Activation of LXR in Breast Cancer Cells.
Hutchinson SA; Lianto P; Moore JB; Hughes TA; Thorne JL
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269628
[TBL] [Abstract][Full Text] [Related]
19. SNVSniffer: an integrated caller for germline and somatic single-nucleotide and indel mutations.
Liu Y; Loewer M; Aluru S; Schmidt B
BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):47. PubMed ID: 27489955
[TBL] [Abstract][Full Text] [Related]
20. Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition.
Lau TTY; May CM; Sefid Dashti ZJ; Swanson L; Starks ER; Parker JDK; Moore RA; Tucker T; Bosdet I; Young SS; Santos JL; Compton K; Heidary N; Hoang L; Schrader KA; Sun S; Kwon JS; Tinker AV; Karsan A
J Mol Diagn; 2021 Sep; 23(9):1145-1158. PubMed ID: 34197922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
